Eupraxia Pharmaceuticals INC. 6-K Filing
Ticker: EPRX · Form: 6-K · Filed: Nov 4, 2025 · CIK: 1581178
Sentiment: neutral
Filing Stats: 246 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2025-11-04 16:01:11
Filing Documents
- d35661d6k.htm (6-K) — 11KB
- d35661dex991.htm (EX-99.1) — 494KB
- d35661dex992.htm (EX-99.2) — 294KB
- d35661dex993.htm (EX-99.3) — 21KB
- d35661dex994.htm (EX-99.4) — 12KB
- d35661dex995.htm (EX-99.5) — 12KB
- g35661dsp32.jpg (GRAPHIC) — 23KB
- g35661g37u32.jpg (GRAPHIC) — 10KB
- 0001193125-25-264619.txt ( ) — 889KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Eupraxia Pharmaceuticals Inc. Date: November 4, 2025 By: /s/ Alex Rothwell Name: Alex Rothwell Title: Chief Financial Officer